BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 177182)

  • 1. Localized submassive liver cell necrosis as a terminal event of liver carcinoma.
    Okuda K; Musha H; Kanno H; Igarashi M; Nakano M
    Cancer; 1976 Apr; 37(4):1965-72. PubMed ID: 177182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma.
    Shimokawa Y; Okuda K; Kubo Y; Kaneko A; Arishima T; Nagata E; Hashimoto M; Sawa Y; Nagasaki Y; Kojiro M; Sakamoto K; Nakashima T
    Cancer; 1977 Jul; 40(1):319-24. PubMed ID: 195707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of liver function tests in hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Thambyrajah V; Timor J
    Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactic dehydrogenase isoenzyme alterations in malignant disease of the liver.
    Massey WH; Dennis DL; Fletcher WS; Wood DC
    Am J Surg; 1971 Aug; 122(2):209-16. PubMed ID: 4327173
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular carcinoma presenting as intracranial metastasis.
    Lee JP; Lee ST
    Surg Neurol; 1988 Oct; 30(4):316-20. PubMed ID: 2459797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases.
    al-Sarraf M; Go TS; Kithier K; Vaitkevicius VK
    Cancer; 1974 Feb; 33(2):574-82. PubMed ID: 4360057
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transcatheter arterial embolization therapy for hepatoma--assessment in blood chemistry (author's transl)].
    Yamada R; Nakatsuka H; Nakamura K; Sato M; Itami M; Kobayashi N; Tamaoka K; Oda J; Minakuchi K; Onoyama Y; Kanno T; Marumo T; Monna T; Yamamoto S
    Nihon Shokakibyo Gakkai Zasshi; 1981 Feb; 78(2):214-21. PubMed ID: 6264184
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatocellular carcinoma: clinicopathological aspects.
    Okuda K
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S314-8. PubMed ID: 9407352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma.
    Seki T; Tamai T; Nakagawa T; Imamura M; Nishimura A; Yamashiki N; Ikeda K; Inoue K
    Cancer; 2000 Sep; 89(6):1245-51. PubMed ID: 11002219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of intrahepatic recurrence after curative resection of hepatocellular carcinoma.
    Hanazaki K; Matsushita A; Nakagawa K; Misawa R; Amano J
    Hepatogastroenterology; 2005; 52(62):580-6. PubMed ID: 15816482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum activity of transaminase (SGOT, SGPT) and lactate dehydrogenase (SLDH) in normal pregnancy and during delivery].
    Székely JA; Fritzsch W
    Zentralbl Gynakol; 1969 Sep; 91(36):1169-74. PubMed ID: 5370046
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical implications of telomerase activity in resected hepatocellular carcinoma.
    Kanamaru T; Yamamoto M; Morita Y; Itoh T; Kuroda Y; Hisatomi H
    Int J Mol Med; 1999 Sep; 4(3):267-71. PubMed ID: 10425277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum activities of lysosomal enzymes in patients with liver cell carcinoma.
    Nagasue N; Inokuchi K; Kanashima R
    Dig Dis Sci; 1982 May; 27(5):454-8. PubMed ID: 6176411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma.
    Aoki T; Imamura H; Hasegawa K; Matsukura A; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Arch Surg; 2004 Jul; 139(7):766-74. PubMed ID: 15249411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute renal failure after ligation of the hepatic artery.
    Kim DK; Penneman R; Kallum B; Carrillo M; Scheiner E; Fortner JG
    Surg Gynecol Obstet; 1976 Sep; 143(3):391-4. PubMed ID: 959959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiotherapy of liver metastases].
    Dallüge KH; Eichhorn HJ; Scholz P; Hüttner J
    Strahlentherapie; 1972 Nov; 144(5):522-32. PubMed ID: 4119035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systolic liver sounds in primary liver carcinoma].
    Zuidema PJ
    Med Klin; 1968 Jul; 63(29):1133-5. PubMed ID: 4305191
    [No Abstract]   [Full Text] [Related]  

  • 18. [Enzyme diagnosis of the metastaic liver].
    Schmidt E; Schmidt FW
    Dtsch Med Wochenschr; 1968 Jun; 93(24):1198-200. PubMed ID: 5651557
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
    Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
    Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Ikeda M; Okusaka T; Furuse J; Mitsunaga S; Ueno H; Yamaura H; Inaba Y; Takeuchi Y; Satake M; Arai Y
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):463-70. PubMed ID: 23812005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.